PL3387156T3 - Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych - Google Patents

Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych

Info

Publication number
PL3387156T3
PL3387156T3 PL16820182T PL16820182T PL3387156T3 PL 3387156 T3 PL3387156 T3 PL 3387156T3 PL 16820182 T PL16820182 T PL 16820182T PL 16820182 T PL16820182 T PL 16820182T PL 3387156 T3 PL3387156 T3 PL 3387156T3
Authority
PL
Poland
Prior art keywords
metabolic disorders
lactobacillus casei
treating obesity
associated metabolic
obesity
Prior art date
Application number
PL16820182T
Other languages
English (en)
Inventor
Barry Kiely
Eileen Frances Murphy
Selena HEALY
Original Assignee
Precisionbiotics Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precisionbiotics Group Limited filed Critical Precisionbiotics Group Limited
Publication of PL3387156T3 publication Critical patent/PL3387156T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL16820182T 2015-12-11 2016-12-09 Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych PL3387156T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15199657 2015-12-11
PCT/EP2016/080449 WO2017097984A1 (en) 2015-12-11 2016-12-09 Lactobacillus casei for treating obesity and associated metabolic disorders
EP16820182.0A EP3387156B1 (en) 2015-12-11 2016-12-09 Lactobacillus casei for treating obesity and associated metabolic disorders

Publications (1)

Publication Number Publication Date
PL3387156T3 true PL3387156T3 (pl) 2020-11-16

Family

ID=55083278

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16820182T PL3387156T3 (pl) 2015-12-11 2016-12-09 Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych

Country Status (7)

Country Link
US (2) US20180360092A1 (pl)
EP (1) EP3387156B1 (pl)
CN (1) CN109312297B (pl)
DK (1) DK3387156T3 (pl)
ES (1) ES2807915T3 (pl)
PL (1) PL3387156T3 (pl)
WO (1) WO2017097984A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10741091B2 (en) * 2016-02-05 2020-08-11 ThinkCERCA.com, Inc. Methods and systems for mitigating the effects of intermittent network connectivity in educational settings
TWI739078B (zh) * 2018-04-25 2021-09-11 日商曾根農場股份有限公司 脂肪累積抑制用組成物
US11963986B2 (en) * 2018-10-24 2024-04-23 Novozymes A/S Probiotic supplement for metabolic health
CN109628358B (zh) 2019-02-20 2021-03-19 无限极(中国)有限公司 一种复合益生菌及其应用
CN113207960B (zh) * 2020-08-31 2023-02-28 内蒙古蒙牛乳业(集团)股份有限公司 改善肥胖的乳双歧杆菌MN-Gup发酵乳及制备方法
CN114145461B (zh) * 2021-11-26 2023-10-31 广州能靓生物技术有限公司 一种缓解非酒精性脂肪肝的益生菌组合物
CN114617265B (zh) * 2022-05-16 2022-08-09 天津创源生物技术有限公司 一种灭活干酪乳杆菌iob-p9后生元粉在降糖方面的应用
CN116590184B (zh) * 2023-04-28 2024-03-08 山东康祐生物科技有限公司 一种提升免疫力的后生元制品及其制备方法和应用
CN116590181B (zh) * 2023-04-28 2024-01-12 微康益生菌(苏州)股份有限公司 一种改善微塑料污染引起的炎症反应的副干酪乳杆菌及其应用
CN117431188B (zh) * 2023-11-29 2025-05-13 浙江大学 具有改善非酒精性肝病的植物乳植杆菌zjuids14及其应用
CN117770313A (zh) * 2023-12-27 2024-03-29 微康益生菌(苏州)股份有限公司 一种抑制脂肪积累的复合益生菌剂及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049303A1 (en) * 1996-06-21 1997-12-31 Quest International B.V. Fermentation of fruit products
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2009102270A (ja) * 2007-10-24 2009-05-14 Tsujido Kagaku Kk 脂肪代謝抑制剤
EP2065048A1 (en) * 2007-11-30 2009-06-03 Institut Pasteur Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
WO2015172191A1 (en) * 2014-05-12 2015-11-19 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
CN104212740A (zh) * 2014-08-14 2014-12-17 任发政 干酪乳杆菌及其应用以及功能食品组合物

Also Published As

Publication number Publication date
EP3387156B1 (en) 2020-04-29
CN109312297B (zh) 2022-09-23
EP3387156A1 (en) 2018-10-17
US20180360092A1 (en) 2018-12-20
US11490643B2 (en) 2022-11-08
CN109312297A (zh) 2019-02-05
DK3387156T3 (da) 2020-08-03
ES2807915T3 (es) 2021-02-24
WO2017097984A1 (en) 2017-06-15
US20210282444A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
PL3386523T3 (pl) Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych
IL257978A (en) Use of pasteurized acrementia to treat metabolic diseases
IL251066A0 (en) Preparations and methods for the treatment of metabolic disorders
ZA201705812B (en) Recombinant probiotic bacteria
ZA201700311B (en) Compositions and methods of use for treating metabolic disorders
IL257683A (en) Milk fermentation bacteria that inhibit acidification
SG11201703193XA (en) Treatment for depression and depressive disorders
PL3265043T3 (pl) Urządzenie pomagające w przenoszeniu i ćwiczeniach pacjenta
ZA201704590B (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
GB201400915D0 (en) Rights transfer and verification
IL250715A0 (en) Preparations and methods for the treatment of cultural disorders
DK3387156T3 (da) Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme
EP3142699A4 (en) Compositions and methods for treating metabolic disorders
SG11201607557WA (en) Novel lactobacillus paracasei strain
GB201409541D0 (en) Probiotic Bacteria
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
SG11201604840TA (en) Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
GB201418809D0 (en) Therapeutic agents and uses thereof
PL3454873T3 (pl) Kompozycja probiotyczna i jej zastosowania
GB201411150D0 (en) Novel aptamers and therapeutic uses thereof
GB201414706D0 (en) Calcitonin mimetics for treating diseases and disorders
PL3031931T3 (pl) Bakteria Lactobacillus rhamnosus klasy spożywczej